Efficacy News and Research

RSS

Analytical and clinical evaluation of antigen-based rapid diagnostic tests against the most encountered SARS-CoV-2 variants

A recent study has assessed the sensitivity of Ag-RDTs against the most prevalent BA.5 Omicron sub-lineage.

2 Aug 2023

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

In a recent study, researchers working at Ohio State University in the United States of America (USA) developed an intranasal subunit vaccine.

2 Aug 2023

IN8bio opens new cancer research lab in Birmingham's Pepper Place

Birmingham's Pepper Place has a striking new addition to its teeming farmers' market and noted food offerings - a multimillion-dollar cancer research laboratory.

1 Aug 2023

RSV vaccines for older adults: 2023 ACIP recommendations

A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.

1 Aug 2023

New device can detect COVID-19 in less than a minute

Benjamin Sumlin, PhD, a senior scientist at Washington University in St. Louis, blows into a device designed by researchers at the university. The device — a breath test that uses a biosensor — could become a tool for use in doctors' offices to quickly diagnose people infected with the virus that causes COVID-19.

1 Aug 2023

Catheter-directed thrombolysis may offer a safer alternative for high-risk patients with pulmonary embolism

Pulmonary embolism (PE), a life-threatening condition caused by blood clots in the lung, has long posed a significant risk to patients worldwide.

31 Jul 2023

Coordination between neuronal activity and brain oxygenation altered in older people

Researchers investigating brain activity in older people say the coordination between neuronal activity and the brain's oxygenation is altered.

31 Jul 2023

Researchers investigate the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma

Researchers investigated the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma.

31 Jul 2023

Novel vaccine targets inflamed brain cells in Alzheimer's to modify the course of disease

A novel vaccine that targets inflamed brain cells associated with Alzheimer's disease may hold the key to potentially preventing or modifying the course of the disease, according to preliminary research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2023.

31 Jul 2023

MUSC study to determine optimal dose of transcranial magnetic stimulation for MCI

With more than $3.7 million in funding from the National Institute on Aging, Medical University of South Carolina neuropsychologist Andreana Benitez, Ph.D., of the Department of Neurology in the College of Medicine will lead a phase II clinical trial to determine the optimal dose of transcranial magnetic stimulation, or TMS, needed to improve symptoms for patients with depression and mild cognitive impairment, or MCI.

28 Jul 2023

Scientists discover a way to produce true structure of naturally-occurring anti-HIV compound

Having control over how a dish is cooked is always a good idea. Taking a hint from the kitchen, scientists appear to have discovered a way to produce a true structure of the rare but naturally-occurring anti-HIV compound Lancilactone C from start to finish.

28 Jul 2023

Study: 7 saw palmetto products effective in addressing urinary tract symptoms

A new study published in the Journal of Urology Open Plus reveals that 7 saw palmetto products met the identity and potency standards to effectively address urinary tract symptoms associated with an enlarged prostate.

28 Jul 2023

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that The Lancet Infectious Diseases published results from the company's OVX836-003 study under the title, "Immunogenicity, safety and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: randomized, double-blind placebo-controlled, Phase 2a trial."

27 Jul 2023

New gene editing approach could revolutionize the treatment of blood disorders

In a step forward in the development of genetic medicines, researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification of diseased blood cells directly within the body.

27 Jul 2023

Researchers study the impact of teleneurology program on timeliness of access to neurological care

Accessing neurologic care often presents physical, geographical and financial challenges to patients, many of whom face chronic and disabling conditions.

27 Jul 2023

New technology could help amputees feel temperature in their phantom limbs

Johns Hopkins Applied Physics Laboratory (APL) researchers have developed one of the world's smallest, most intense and fastest refrigeration devices, the wearable thin-film thermoelectric cooler (TFTEC), and teamed with neuroscientists to help amputees perceive a sense of temperature with their phantom limbs.

27 Jul 2023

Harvard researchers develop ink that enables 3D printing of beating heart tissues

Over the last decade, advances in 3D printing have unlocked new possibilities for bioengineers to build heart tissues and structures.

27 Jul 2023

MU researcher receives $3 million grant to use gene editing for investigating the building blocks of disease

In a new study funded by a $3 million grant from the National Institutes of Health (NIH), University of Missouri researcher Kiho Lee, an associate professor in the College of Agriculture, Food and Natural Resources, will use gene editing to investigate the building blocks of disease.

27 Jul 2023

Henry Ford Health researcher wins grant to study circulating cell-free DNA methylation as a tool for glioma detection

Houtan Noushmehr, Ph.D., a researcher at Henry Ford Health, has been awarded a prestigious R01 grant of nearly $2.9M from the National Institutes of Health (NIH) to support a research project titled, "Circulating cell-free DNA methylation as an accurate tool for detection and clinical follow-up of glioma."

27 Jul 2023

Increasing COVID-19 booster vaccine uptake: The impact of one-time personal reminder messages

The rate of COVID-19 booster vaccination can be increased considerably by sending one-time personal reminders.

27 Jul 2023

Efficacy News and Research

Analytical and clinical evaluation of antigen-based rapid diagnostic tests against the most encountered SARS-CoV-2 variants

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

IN8bio opens new cancer research lab in Birmingham's Pepper Place

RSV vaccines for older adults: 2023 ACIP recommendations

New device can detect COVID-19 in less than a minute

Catheter-directed thrombolysis may offer a safer alternative for high-risk patients with pulmonary embolism

Coordination between neuronal activity and brain oxygenation altered in older people

Researchers investigate the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma

Novel vaccine targets inflamed brain cells in Alzheimer's to modify the course of disease

MUSC study to determine optimal dose of transcranial magnetic stimulation for MCI

Scientists discover a way to produce true structure of naturally-occurring anti-HIV compound

Study: 7 saw palmetto products effective in addressing urinary tract symptoms

Broad-spectrum influenza vaccine candidate shows safety, immunogenicity data across three dose levels

New gene editing approach could revolutionize the treatment of blood disorders

Researchers study the impact of teleneurology program on timeliness of access to neurological care

New technology could help amputees feel temperature in their phantom limbs

Harvard researchers develop ink that enables 3D printing of beating heart tissues

MU researcher receives $3 million grant to use gene editing for investigating the building blocks of disease

Henry Ford Health researcher wins grant to study circulating cell-free DNA methylation as a tool for glioma detection

Increasing COVID-19 booster vaccine uptake: The impact of one-time personal reminder messages

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News